5 key lessons learned in the US about weight loss drugs
The US market for weight loss drugs is set to expand on a massive global scale. But how should the global health community prepare for GLP-1 expansion?
Sean Duffy is the Co-founder and CEO of Omada Health, a between-visit care provider for prediabetes/obesity, diabetes, hypertension, and musculoskeletal disorders. He has dedicated his professional life to harnessing the cross-functional impact of technology, design, and care delivery to transform care experiences for patients. As a former MD/MBA candidate at Harvard, he also holds a BS in neuroscience from Columbia University. He has written extensively about digital health and the future of healthcare in The New England Journal of Medicine, The Wall Street Journal, Forbes, and TechCrunch, among other publications. Prior to Omada, Sean worked at both Google and IDEO.